Bangladesh’s pharmaceutical industry continues to experience strong market growth in 2026, with the total pharmaceutical market reaching BDT 40,885 crore according to the provided IQVIA MAT Q2 2026 data. The market recorded 10.6% growth, while the four-year compound annual growth rate (CAGR) stood at 11.4%.
The latest Bangladesh pharma market ranking demonstrates the strength of established pharmaceutical manufacturers while also showing significant growth among several emerging and mid-sized companies.
This analysis presents the top 30 pharmaceutical companies in Bangladesh, including their market value, market share, growth rate and four-year CAGR.
Bangladesh Pharmaceutical Market at a Glance
The Bangladesh pharmaceutical market has become increasingly competitive, with local manufacturers accounting for a substantial portion of the industry’s market activity.
According to the provided IQVIA MAT Q2 2026 data:
| Market Indicator | Q2 2026 |
|---|---|
| Total Pharmaceutical Market | BDT 40,885 crore |
| Total Market Growth | 10.6% |
| Four-Year CAGR | 11.4% |
| Companies Listed | 30 |
| No. 1 Company | Square Pharmaceuticals |
| Leading Market Share | 17.0% |
The figures indicate that the Bangladesh pharmaceutical market in 2026 remains on a strong growth trajectory.
Top 30 Pharmaceutical Companies in Bangladesh 2026
The following table presents the ranking based on the supplied IQVIA MAT Q2 2026 pharmaceutical market data.
| Rank | Pharmaceutical Company | Market Value (BDT Crore) | Market Share | Growth | 4-Year CAGR |
|---|---|---|---|---|---|
| 1 | Square | 6,936 | 17.0% | 7.8% | 8.6% |
| 2 | Incepta Pharma | 5,139 | 12.6% | 8.9% | 14.1% |
| 3 | Beximco | 3,994 | 9.8% | 12.9% | 12.7% |
| 4 | Healthcare Pharma | 3,046 | 7.5% | 6.6% | 12.8% |
| 5 | Renata | 2,334 | 5.7% | 9.8% | 14.2% |
| 6 | Eskayef | 1,998 | 4.9% | 9.3% | 15.6% |
| 7 | Aristopharma | 1,918 | 4.7% | 18.9% | 16.6% |
| 8 | Opsonin Pharma | 1,899 | 4.7% | 9.5% | 10.7% |
| 9 | Popular Pharma | 1,637 | 4.0% | 7.4% | 22.7% |
| 10 | Radiant Pharma | 1,616 | 4.0% | 18.8% | 14.2% |
| 11 | ACME | 1,585 | 3.9% | 11.2% | 13.4% |
| 12 | A.C.I. | 1,530 | 3.7% | 9.6% | 13.5% |
| 13 | Drug International | 1,220 | 3.0% | 18.7% | 9.4% |
| 14 | Unimed & Unhealth | 910 | 2.2% | 5.4% | 8.7% |
| 15 | Beacon Pharma | 559 | 1.4% | 19.4% | 11.5% |
| 16 | Ziska | 471 | 1.2% | 32.4% | 12.3% |
| 17 | Novo Nordisk | 425 | 1.0% | 14.6% | -0.6% |
| 18 | Nipro JMI Pharma | 422 | 1.0% | 8.6% | 10.3% |
| 19 | Ibn Sina | 360 | 0.9% | 23.5% | 7.1% |
| 20 | Nuvista Pharma | 333 | 0.8% | 20.9% | 11.4% |
| 21 | Sun Pharma | 330 | 0.8% | 41.4% | 6.1% |
| 22 | Navana | 328 | 0.8% | 15.6% | 16.5% |
| 23 | Synovia Pharma PLC | 328 | 0.8% | 21.7% | 12.2% |
| 24 | Nevian Lifesci. | 307 | 0.8% | -0.7% | -0.3% |
| 25 | Roche | 281 | 0.7% | 4.6% | 6.1% |
| 26 | Orion Pharma Ltd. | 185 | 0.5% | -9.1% | -1.8% |
| 27 | Eli Lilly | 162 | 0.4% | 7.5% | 12.2% |
| 28 | Servier | 162 | 0.4% | 11.5% | 5.6% |
| 29 | Everest Pharma | 67 | 0.2% | 44.7% | 19.7% |
| 30 | OSL Pharma | 53 | 0.1% | 84.3% | 11.1% |
Source: IQVIA MAT Q2 2026 data supplied for this analysis.
Market Leader: Square Pharmaceuticals
Square Pharmaceuticals remains the largest pharmaceutical company in Bangladesh according to the supplied MAT Q2 2026 data.
The company recorded a market value of approximately BDT 6,936 crore, representing a 17.0% market share.
Incepta Pharma ranked second with a market value of BDT 5,139 crore and a 12.6% market share, followed by Beximco with BDT 3,994 crore and a 9.8% market share.
The top three companies therefore maintain a substantial position within the overall Bangladesh pharmaceutical market.
Top 10 Pharma Companies in Bangladesh
The top 10 pharmaceutical manufacturers in the supplied ranking are:
- Square Pharmaceuticals
- Incepta Pharma
- Beximco
- Healthcare Pharma
- Renata
- Eskayef
- Aristopharma
- Opsonin Pharma
- Popular Pharma
- Radiant Pharma
Together, these companies represent a significant portion of the pharmaceutical market.
The ranking also demonstrates that market leadership and growth rate are not necessarily the same. Some companies outside the top five achieved substantially higher year-on-year growth than the largest manufacturers.
Fastest-Growing Pharmaceutical Companies in Bangladesh
One of the most interesting aspects of the IQVIA MAT Q2 2026 data is the variation in company growth rates.
The highest growth rates among the listed companies were:
| Company | Growth |
|---|---|
| OSL Pharma | 84.3% |
| Everest Pharma | 44.7% |
| Sun Pharma | 41.4% |
| Ziska | 32.4% |
| Ibn Sina | 23.5% |
| Synovia Pharma PLC | 21.7% |
| Nuvista Pharma | 20.9% |
| Beacon Pharma | 19.4% |
| Aristopharma | 18.9% |
| Radiant Pharma | 18.8% |
These figures show that several companies are expanding considerably faster than the overall pharmaceutical market growth of 10.6%.
However, percentage growth should always be considered alongside market value and market size. A smaller company can record a very high percentage increase from a relatively low base.
Popular Pharma Shows Strong Long-Term CAGR
The four-year CAGR provides another useful way to understand the development of the Bangladesh pharma industry.
Among the companies listed, Popular Pharma recorded the highest four-year CAGR at 22.7%.
Other companies with notable four-year CAGR figures include:
- Everest Pharma — 19.7%
- Aristopharma — 16.6%
- Navana — 16.5%
- Eskayef — 15.6%
- Renata — 14.2%
- Radiant Pharma — 14.2%
- Incepta Pharma — 14.1%
- A.C.I. — 13.5%
- ACME — 13.4%
The data suggests that several pharmaceutical companies have maintained substantial long-term expansion even when their latest annual growth rate varies.
Pharmaceutical Market Growth in Bangladesh
The total market growth of 10.6% indicates continued expansion of the pharmaceutical sector.
Several factors are generally important to pharmaceutical market performance, including:
- Increasing healthcare demand
- Expansion of therapeutic categories
- New product introductions
- Growth of domestic pharmaceutical manufacturing
- Increasing healthcare awareness
- Expansion of distribution networks
- Development of specialized medicines
- Export opportunities
- Investment in pharmaceutical manufacturing facilities
- Regulatory and quality-system improvements
The combination of these factors contributes to the evolving competitive environment within the Bangladesh pharmaceutical industry.
Bangladesh Pharma Industry: Increasing Competition
The 2026 market ranking illustrates a highly competitive pharmaceutical environment.
While the largest companies continue to hold significant market shares, a number of mid-sized manufacturers are recording growth rates substantially above the market average.
This creates an increasingly competitive environment in areas such as:
Product Portfolio
Companies are expanding their portfolios across different therapeutic categories and introducing new products to meet changing healthcare requirements.
Manufacturing Capacity
Investment in manufacturing infrastructure and technology remains important for companies seeking sustainable long-term growth.
Quality Assurance and GMP Compliance
Strong Quality Assurance (QA), Quality Control (QC), Good Manufacturing Practice (GMP) and regulatory compliance systems are increasingly important for pharmaceutical manufacturers operating in domestic and international markets.
Regulatory Compliance
Compliance with national and international regulatory requirements is an important component of pharmaceutical business development, particularly for companies targeting export markets.
Export Opportunities
Bangladesh’s pharmaceutical industry has increasingly focused on international markets, creating opportunities for manufacturers with appropriate regulatory approvals, manufacturing standards and product portfolios.
What Does the IQVIA MAT Q2 2026 Ranking Tell Us?
Several key observations can be made from the data.
1. Bangladesh’s pharmaceutical market continues to grow
The total market value reached BDT 40,885 crore, with overall growth of 10.6%.
2. Market leadership remains concentrated
The largest pharmaceutical manufacturers maintain significant market shares, particularly Square, Incepta and Beximco.
3. Several mid-sized companies are growing rapidly
Companies outside the top five have recorded some of the strongest growth rates in the ranking.
4. Long-term growth differs significantly between companies
The four-year CAGR ranges considerably across the listed manufacturers, demonstrating different growth trajectories.
5. High growth does not always mean high market share
Some companies with very high growth rates still have relatively small overall market shares. Market size and growth therefore need to be evaluated together.
Future Outlook for the Bangladesh Pharmaceutical Industry
The outlook for the Bangladesh pharmaceutical market remains closely linked to domestic healthcare demand, manufacturing capability, regulatory compliance, product development and international market opportunities.
Competition is likely to remain strong as pharmaceutical manufacturers seek to increase market share while maintaining product quality and operational efficiency.
For pharmaceutical professionals, this market expansion also creates opportunities across multiple career areas, including:
- Pharmaceutical Quality Assurance
- Quality Control
- Production
- Regulatory Affairs
- Research & Development
- Pharmacovigilance
- Engineering and Maintenance
- Supply Chain Management
- Validation
- Good Manufacturing Practice (GMP)
- Quality Management Systems (QMS)
As pharmaceutical companies expand their operations, demand for technically competent and regulatory-focused professionals is also expected to remain important.
Final Thoughts
The IQVIA MAT Q2 2026 Bangladesh pharmaceutical market ranking provides a useful snapshot of the country’s rapidly evolving pharmaceutical sector.
With a total market value of BDT 40,885 crore, market growth of 10.6%, and a four-year CAGR of 11.4%, the industry continues to demonstrate strong commercial momentum.
The rankings also reveal an important trend: market size, market share and growth rate can tell very different stories about a pharmaceutical company. While established manufacturers dominate the market in terms of value and share, several companies are recording significantly higher growth rates.
For anyone following the Bangladesh pharma industry, pharmaceutical companies in Bangladesh, pharma market share, pharmaceutical market growth or pharma industry trends in 2026, the IQVIA MAT Q2 data offers valuable insight into the current competitive landscape.